Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03552029 |
|---|---|
| Brief Title: | Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML) |
| First Submitted : | May 17, 2018 |
| First Submitted that Met QC Criteria : | May 29, 2018 |
| First Posted : | June 11, 2018 |
| Results First Submitted : | December 13, 2021 |
| Results First Submitted that Met QC Criteria : | March 14, 2022 |
| Results First Posted : | May 20, 2022 |
| Last Update Submitted that Met QC Criteria : | March 14, 2022 |
| Last Update Posted : | May 20, 2022 |